by Brad N. Taylor, Ph.D. | Dec 12, 2022
CAR T therapy is a revolutionary new cancer treatment that relies on engineering a patient’s immune cells. High transduction efficiency is key to its therapeutic success. Nucleus Biologics has launched NB-ROC™, a serum free media formulated by T cell researchers with...
by Dr. Alyssa Master | Jun 24, 2021
The surge of cellular T cell-based immunotherapies has prompted more and more researchers to take an interest in these specialized immune cells. Whether you are brand new to the cell therapy field or an experienced immunologist, learning to work with a new cell type...
by Brad N. Taylor, Ph.D. | Jun 14, 2021
Our mission is to speed the time from scientific discovery to cure by driving reproducibility through Precision Cell Culture products and tools. We deliver innovative, transparent, and cGMP products and services with the goal of disrupting the market and eliminating...
by Dr. Alyssa Master | Feb 9, 2019
Companies with breakthrough CAR T products need to focus not just on the science but also on how to successfully bring their therapies to market. Because cell and gene therapies are unlike conventional treatments, everything from sales & marketing to manufacturing...
by Dr. Alyssa Master | Jan 30, 2019
Do you need a scientific crash course in CAR T cell therapy? The Nucleus Team has curated three great scientific reviews written by leaders in the field of CAR T cells so you can stay up-to-date on mechanisms of action, first and second generation CARs, and challenges...
